CompletedNCT00465608
Propranolol in PTSD
It focuses on PTSD and currently lists study information in France.
PTSDDrugFrom 18 Years to 65 Years
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Toulouse, FranceSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
Study information
Study start dateApril 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- University Hospital, Toulouse
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- France
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00465608
- Official title
- Reduction of the Traumatic Memory by Reconsolidation Blockade: A Pilot Study
Recruitment & locations
CompletedToulouse
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Toulouse, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including propranolol.
Who was this study for?
Listed age limits: 18 years to 65 years.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
CompletedNCT03045016
Efficacy of Prazosin in Preventing PTSD
This study is completed. It focuses on PTSD and currently lists study information in France.
CompletedNCT04950426
Impact of PTSD Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
This study is completed. It focuses on PTSD and currently lists study information in France.
CompletedEUCTR 2020-005956-39
Treatment of pediatric Post-traumatic Stress Disorder with memory reactivation under the influence of propranolol: A randomized placebo-controlled trial
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.